Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway

Hormone replacement therapy has been a conventional treatment for postmenopausal symptoms in women. However, it has potential risks of breast and endometrial cancers. The aim of this study was to evaluate the oestrogenicity of a plant-based compound, mimosine, in MCF-7 cells by in silico model. Cell...

Full description

Bibliographic Details
Main Authors: Huq, Akm Moyeenul, Lam, Kok Wai, Rullah, Kamal, Mohd Aluwi, Mohd Fadhlizil Fasihi, Stanslas, Johnson, Jamal, Jamia Azdina
Format: Article
Language:English
Published: Blackwell 2019
Online Access:http://psasir.upm.edu.my/id/eprint/81528/
http://psasir.upm.edu.my/id/eprint/81528/1/Oestrogenic%20activity%20of%20mimosine%20on%20MCF-7%20breast%20cancer%20cell%20line%20through%20the%20ER%CE%B1-mediated%20pathway.pdf
_version_ 1848859125770878976
author Huq, Akm Moyeenul
Lam, Kok Wai
Rullah, Kamal
Mohd Aluwi, Mohd Fadhlizil Fasihi
Stanslas, Johnson
Jamal, Jamia Azdina
author_facet Huq, Akm Moyeenul
Lam, Kok Wai
Rullah, Kamal
Mohd Aluwi, Mohd Fadhlizil Fasihi
Stanslas, Johnson
Jamal, Jamia Azdina
author_sort Huq, Akm Moyeenul
building UPM Institutional Repository
collection Online Access
description Hormone replacement therapy has been a conventional treatment for postmenopausal symptoms in women. However, it has potential risks of breast and endometrial cancers. The aim of this study was to evaluate the oestrogenicity of a plant-based compound, mimosine, in MCF-7 cells by in silico model. Cell viability and proliferation, ERα-SRC1 coactivator activity and expression of specific ERα-dependent marker TFF1 and PGR genes were evaluated. Binding modes of 17β-oestradiol and mimosine at the ERα ligand binding domain were compared using docking and molecular dynamics simulation experiments followed by binding interaction free energy calculation with molecular mechanics/Poisson-Boltzmann surface area. Mimosine showed increased cellular viability (64,450 cells/ml) at 0.1 μM with significant cell proliferation (120.5%) compared to 17β-oestradiol (135.2%). ER antagonist tamoxifen significantly reduced proliferative activity mediated by mimosine (49.9%). Mimosine at 1 μM showed the highest ERα binding activity through increased SRC1 recruitment at 186.9%. It expressed TFF1 (11.1-fold at 0.1 μM) and PGR (13.9-fold at 0.01 μM) genes. ERα-mimosine binding energy was -49.9 kJ/mol, and it interacted with Thr347, Gly521 and His524 of ERα-LBD. The results suggested that mimosine has oestrogenic activity.
first_indexed 2025-11-15T12:24:22Z
format Article
id upm-81528
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T12:24:22Z
publishDate 2019
publisher Blackwell
recordtype eprints
repository_type Digital Repository
spelling upm-815282020-10-30T12:25:54Z http://psasir.upm.edu.my/id/eprint/81528/ Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway Huq, Akm Moyeenul Lam, Kok Wai Rullah, Kamal Mohd Aluwi, Mohd Fadhlizil Fasihi Stanslas, Johnson Jamal, Jamia Azdina Hormone replacement therapy has been a conventional treatment for postmenopausal symptoms in women. However, it has potential risks of breast and endometrial cancers. The aim of this study was to evaluate the oestrogenicity of a plant-based compound, mimosine, in MCF-7 cells by in silico model. Cell viability and proliferation, ERα-SRC1 coactivator activity and expression of specific ERα-dependent marker TFF1 and PGR genes were evaluated. Binding modes of 17β-oestradiol and mimosine at the ERα ligand binding domain were compared using docking and molecular dynamics simulation experiments followed by binding interaction free energy calculation with molecular mechanics/Poisson-Boltzmann surface area. Mimosine showed increased cellular viability (64,450 cells/ml) at 0.1 μM with significant cell proliferation (120.5%) compared to 17β-oestradiol (135.2%). ER antagonist tamoxifen significantly reduced proliferative activity mediated by mimosine (49.9%). Mimosine at 1 μM showed the highest ERα binding activity through increased SRC1 recruitment at 186.9%. It expressed TFF1 (11.1-fold at 0.1 μM) and PGR (13.9-fold at 0.01 μM) genes. ERα-mimosine binding energy was -49.9 kJ/mol, and it interacted with Thr347, Gly521 and His524 of ERα-LBD. The results suggested that mimosine has oestrogenic activity. Blackwell 2019 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/81528/1/Oestrogenic%20activity%20of%20mimosine%20on%20MCF-7%20breast%20cancer%20cell%20line%20through%20the%20ER%CE%B1-mediated%20pathway.pdf Huq, Akm Moyeenul and Lam, Kok Wai and Rullah, Kamal and Mohd Aluwi, Mohd Fadhlizil Fasihi and Stanslas, Johnson and Jamal, Jamia Azdina (2019) Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway. Chemical Biology and Drug Design, 93 (3). pp. 222-231. ISSN 1747-0277 https://pubmed.ncbi.nlm.nih.gov/30251480/ 10.1111/cbdd.13404. Epub 2018 Oct 21
spellingShingle Huq, Akm Moyeenul
Lam, Kok Wai
Rullah, Kamal
Mohd Aluwi, Mohd Fadhlizil Fasihi
Stanslas, Johnson
Jamal, Jamia Azdina
Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway
title Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway
title_full Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway
title_fullStr Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway
title_full_unstemmed Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway
title_short Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway
title_sort oestrogenic activity of mimosine on mcf-7 breast cancer cell line through the erα-mediated pathway
url http://psasir.upm.edu.my/id/eprint/81528/
http://psasir.upm.edu.my/id/eprint/81528/
http://psasir.upm.edu.my/id/eprint/81528/
http://psasir.upm.edu.my/id/eprint/81528/1/Oestrogenic%20activity%20of%20mimosine%20on%20MCF-7%20breast%20cancer%20cell%20line%20through%20the%20ER%CE%B1-mediated%20pathway.pdf